Healixia Annual Conference 2025

Thursday, May 22, 2025 from 9:00 AM to 11:00 PM Cross-domains

For our 5-year anniversary, we are organizing our Annual Conference together with EUFEMED in Lamot Conference Center in Mechelen, including a social event in the evening.

As a valued member of Healixia, we would love for you to join us for an informative, inspiring and energizing day!

CLICK HERE TO GO TO THE CONFERENCE WEBSITE AND REGISTER!

(The event is organised by 2Mpact for EUFEMED & Healixia. You will need to create your account on the conference website - this is not your Healixia account - in order to be able to register for this event. Invoices will be sent out by 2Mpact.)

Program:

9:00 - 9:15

Welcome and introductions – Jan de Hoon, EUFEMED & Erik Present, Healixia

9:15 - 9:45

Keynote Presentation - Genetic medicines: setting the scene for treatments of the future – Olivier Harari, Regeneron Genetic Medicines, USA

9:45 - 10:45

Medicines Development for innovative therapies: challenges in early and late clinical development

  • Challenges faced by the sponsor: lessons learned and hurdles to overcome - Anna Rozova, Chiesi Global Rare Disease, USA
  • Challenges faced by the investigator: focus on the treatment of ALS as a rare disease – Philip Van Damme, KU Leuven, Belgium
  • The patient’s perspective as participant in a First-in-Human clinical trial - patient testimony

10:45 - 11:15

Coffee break

11:15 - 12:45

Medicines Development for innovative therapies - challenges in regulation and reimbursement

  • Joint Health Technology Assessment (HTA) in Europe: today and tomorrow? – Marc Van de Casteele, RIZIV-INAMI, Belgium
  • Perspective of industry (Speaker invited)
  • Perspective or regulators (Speaker invited)

12:45 – 13:45

Lunch

13:45 - 15:15

Oxford Debate - Diversity YES, but in Phase I? – With Keith Berelowitz, PatientRx Ltd, UK; Henri Caplain, DNDI, France; Liam Eves, h-Bar Consultants, UK; Kerstin Breihaupt-Grögler, independent consultant, Germany

15:15 – 15:45

Coffee break

15:45 - 17:15

Parallel session A: The new ethical framework

  • Impact of the new versions of the Declaration of Helsinki,  ICH-GCP and WHO guidelines for our future performance of clinical trials – Barbara Baroutsou, IFAPP, Greece
  • The VolREthics Initiative – What will it change? – François Bompart, INSERM Ethics Committee, France
  • eConsent Done Right: A Fit-for-Purpose Study Framework – Hilde Vanaken, TCS, EFGCP, Belgium

 

Parallel session B: Real World Data in Belgium: will Phase IV studies become obsolete?

  • Secondary use of data as a source of Real World Data/Evidence – Annelies Verbiest, UZA, Belgium
  • The Federated Health Innovation Network (FHIN): transform healthcare with data - Kim Denturck & Peter De Jaeger, AZ Delta, Belgium
  • The We Are Platform: a sustainable citizen-centric ecosystem for personal health data – Elfi Goesaert, VITO, Belgium

17:30 - 18:00

Closing Keynote Presentation: Evolving a new framework to optimize drug development – Richard Hargreaves, Bristel Myers Squibb, USA

19:00 - 22:00

Social Event with dinner at Salons Van Dijck, Mechelen

Prices

Ticket type Price
Conference (22/05) for junior scientist/clinician (< 30 years old) € 175.00
Conference (22/05) for members € 275.00
Conference (22/05) for non-members € 350.00

The event is organised by 2Mpact for EUFEMED & Healixia. Registration for the conference can be done at the conference website. You will need to create your account on the conference website in order to be able to register for this event. Invoices will be sent out by 2Mpact.